A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells (Q88622171)
Jump to navigation
Jump to search
scientific article published on 28 July 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells |
scientific article published on 28 July 2017 |
Statements
A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells (English)
E J Cheadle
G Lipowska-Bhalla
S J Dovedi
E Fagnano
C Klein
J Honeychurch